Accessibility Menu
Nakamoto logo

Nakamoto(NASDAQ) NAKA

Current Price$5.11
Market Cap$86.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2024)-96%
5 YearN/A
1 Year-99%
1 Month+27%
Nakamoto last closing stock price
MetricPriceDate
Last closeUSD 4.972026-07-23
Nakamoto stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+25.19%USD 3.972026-07-16
1 month+27.11%USD 3.912026-06-23
3 month-42.21%USD 8.602026-04-24
Year to date-64.61%USD 14.042025-12-31
1 year-98.93%USD 462.402025-07-23
Since inception-96.03%USD 120.802024-05-31

Nakamoto Financials at a Glance

Market Cap

$86.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$3.92M

Net Income (TTM)

-$289.97M

EPS (TTM)

-$43.20

P/E Ratio

-0.12

Dividend

$0.00

Beta (Volatility)

1.80 (High)

Price

$5.11

Volume

44,449.616

Open

$5.01

Previous Close

$4.97

Daily Range

$4.91 - $5.16

52-Week Range

$3.33 - $659.20

Estimated Earnings Date

Aug 4, 2026

NAKA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nakamoto

Kindly MD helps people manage chronic pain and mental health needs. Its clinics offer medical care, therapy, and alternative treatments. Patients use these services to improve daily life and well-being.

What’s in the Kindly MD Toolbox?

  • Patient care services: Medical evaluations, chronic pain management, and therapy; approximately 99.9% of Q2 2025 revenue; targets adults with ongoing health needs.
  • Behavioral health integration: Cognitive behavioral therapy and addiction support; included in patient care; helps those with mental health or substance issues.
  • Alternative medicine: Education and access to medical cannabis and ketamine therapy; part of care services; for patients seeking non-opioid options.
  • Data collection and research: Gathers patient data to improve care; supports evidence-based treatment; used internally and for research partners.
  • Retail health products: Sells health products in clinics and online; 0.1% of Q2 2025 revenue; for patients and general consumers.

Growth Moves: Kindly MD’s Expansion Playbook

  • Changed name from Utah Therapeutic Health Center to Kindly MD in March 2022.
  • Entered merger agreement with Nakamoto Holdings in 2025 to add Bitcoin treasury management.
  • Raised approximately $563.2 million through private investments in public equity (PIPE) in 2025.
  • Closed Bountiful clinic location in 2025 to streamline operations.

Why Kindly MD Stands Out (Without the Hype)

Kindly MD combines medical, behavioral, and alternative care in one clinic. It uses patient data to personalize treatment and reduce opioid use. The company recently added Bitcoin holdings as a treasury asset, diversifying its balance sheet.

Five Things You Need to Know

  • Revenue was $408,527 in Q2 2025, down 36.1% from Q2 2024.
  • Patient care services made up approximately 99.9% of Q2 2025 revenue.
  • Net loss was $2.41 million in Q2 2025, compared to $1.32 million in Q2 2024.
  • Cash and equivalents were $6.02 million as of June 30, 2025.
  • Bitcoin holdings reached 21 BTC, valued at $2.25 million in Q2 2025.

Bottom Line

Kindly MD has shifted from traditional healthcare to a hybrid model blending medical, behavioral, and digital asset strategies. The company faces revenue declines but is adapting through new partnerships and diversified assets.

AI Generated • Apr 16, 2026

Industry

Healthcare Providers and Services

Employees

65

CEO

David Forrest Bailey

Headquarters

Nashville, TN 37203, US

NAKA Financials

Key Financial Metrics (TTM)

Gross Margin

-376.04%

Operating Margin

-8221.82%

Net Income Margin

-7397.76%

Return on Equity

-84.79%

Return on Capital

-27.22%

Return on Assets

-46.71%

Earnings Yield

-8.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$86.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

17.40M

Volume

44.45K

Avg. Volume

301.62K

Financials (TTM)

Gross Profit

-$14.74M

Operating Income

-$322.27M

EBITDA

-$276.76M

Operating Cash Flow

-$45.93M

Capital Expenditure

-$61.38K

Free Cash Flow

-$45.99M

Cash & ST Invst.

$35.30M

Total Debt

$209.74M

Nakamoto Performance Analysis

Nakamoto annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 3,787,07751.2%
20232023-12-31USD 3,768,598-0.5%
20242024-12-31USD 2,719,840-27.8%
20252025-12-31USD 1,821,315-33.0%
Nakamoto sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-29.6%
Q32025-09-30-5.0%
Q42025-12-3114.6%
Q12026-03-31501.9%
Nakamoto annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -17.02N/A
20232023-12-31USD -10.83-36.3%
20242024-12-31USD -26.84147.7%
20252025-12-31USD -10.44-61.1%
Nakamoto sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-105.9%
Q32025-09-30-4700.0%
Q42025-12-31116.7%
Q12026-03-31-642.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$2.68M

+361.7%

Gross Profit

-$4.90M

-1037.1%

Gross Margin

-1.83%

N/A

Market Cap

$86.49MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.33M

N/A

Employees

65

N/A

Net Income

-$238.78M

-22903.5%

EBITDA

-$233.44M

-22921.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$35.30M

+2994.9%

Total Debt

$209.74M

+31373.9%

Accounts Receivable

$5.88M

+43098.2%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$209.74M

+107868.1%

Return on Assets

-46.71%

N/A

Return on Invested Capital

-87.32%

N/A

Free Cash Flow

-$23.29M

-2143.3%

Operating Cash Flow

-$23.29M

-2591.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DHDefinitive Healthcare Corp.
$0.69+0.23%
AMRNAmarin Corporation plc
$13.66+0.44%
CLLSCellectis S.A.
$2.95+6.49%
LYELLyell Immunopharma, Inc.
$12.68-0.78%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.29-0.06%
NOKNokia
$9.24-0.05%
NUNu Holdings
$14.23+0.00%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$44.13+0.02%

Questions About NAKA

What is the current price of Nakamoto?

Nakamoto is trading at $5.11 per share.

What is the 52-week range for Nakamoto?

Over the past 52 weeks, Nakamoto has traded between $3.33 and $659.20.

How much debt does Nakamoto have?

As of the most recent reporting period, Nakamoto reported total debt of $209.74M.

How much cash does Nakamoto have on hand?

Nakamoto reported $35.30M in cash and cash equivalents in its most recent financial results.

What is Nakamoto’s dividend yield?

Nakamoto does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.